5 completed, 5 not yet recruiting, 3 recruiting, 2 active not recruiting. 5 Not applicable, 3 Phase 3, 2 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Not yet recruiting 2, Recruiting 2, Completed 1 |
| Phase 3 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Community-acquired Pneumonia (CAP): new trials by email Literature Review of Community-acquired Pneumonia (CAP) trials Research Report on Community-acquired Pneumonia (CAP)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TCM Cohort for Elderly CAP Traditional Chinese medicine (TCM), Non-traditional Chinese medicine (non-TCM) - Community-acquired Pneumonia (CAP) | Not yet recruiting | Henan University of Traditional Chinese Medicine | 2234 | 2026-08-20 | 2026-09-01 | |
| Lefamulin Post-Market Surveillance Study This is a multicenter, single-arm, non-interventional study. No interventional measures will be adopted. - Community-Acquired Pneumonia (CAP) | Recruiting | Marubeni Pharmaceuticals (Suzhou) Co., Ltd. | 1000 | 2026-06-30 | 2026-08-07 | |
| Multicenter Phase II Trial of NRICM102 Combined With Standard Therapy in Pneumonia NRICM102, Placebo, Intravenous Antibiotic - Mild to Moderate, Community-Acquired Pneumonia (CAP) | Phase 2 | Not yet recruiting | National Research Institute of Chinese Medicine, Ministry of Health and Welfare | 150 | 2026-06-01 | 2026-05-13 |
| Multimodal Assisted Diagnosis for Pediatric Respiratory Diseases Using Questionnaires, Cough Sounds, and Breath Sounds Multimodal respiratory data collection - Asthma (Diagnosis), Community-Acquired Pneumonia (CAP) | Not yet recruiting | Shanghai Children's Medical Center | 1400 | 2026-06-01 | 2026-05-29 | |
| PromotIng Optimal Treatment for Community-acquired PNeumonia in EmErgency Rooms The novel care pathway intervention, Usual Care Alone - Community-Acquired Pneumonia (CAP), Pneumonia | Not applicable | Recruiting | Jeffrey Pernica | 698 | 2026-04-15 | 2026-04-29 |
| Study of Nogapendekin Alfa Inbakicept and iNKT Cells in Critically Ill Adults With Severe Community-Acquired Pneumonia Nogapendekin alfa inbakicept (NAI), agenT-797 - Community-Acquired Pneumonia (CAP), Acute Respiratory Distress Syndrome (ARDS) | Phase 3 | Withdrawn | ImmunityBio, Inc. | 2026-04-15 | 2026-05-08 | |
| A Study to Learn How Effective is PCV20 to Help Stop Adults Who Have a Higher Chance of Getting Pneumonia Receipt of PCV20 - Community-Acquired Pneumonia (CAP) | Active not recruiting | Pfizer | 846279 | 2026-01-21 | 2026-10-27 | |
| Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary Care Antibiotic prescribing according to guidelines - Angina, Acute Bronchiolitis | Not applicable | Recruiting | University Hospital, Caen | 4500 | 2025-12-01 | 2026-01-22 |
| A Study to Learn About How Well the Prevnar 20 Vaccine Works for Pneumonia in People Who Are 65 Years and Older Community-Acquired Pneumonia (CAP) | Active not recruiting | Pfizer | 22234435 | 2025-01-20 | 2026-04-22 | |
| Clinical Trial of Fei Re Qing Granules in the Treatment of Elderly Community-Acquired Pneumonia Fei Re Qing Granules, Routine standard treatments, Placebo granules - Community-Acquired Pneumonia (CAP) | Not applicable | Not yet recruiting | Henan University of Traditional Chinese Medicine | 120 | 2025-01-01 | 2024-12-24 |
| Clinical Impact of Rapid Molecular Testing for Pathogens in Patients With Severe Acute Respiratory Illness : A Pragmatic Trial The BIOFIRE®FILMARRAY® Pneumonia Panel - Community-Acquired Pneumonia (CAP), Pneumonia | Not applicable | Not yet recruiting | National Taiwan University Clinical Trial Center | 800 | 2024-09-20 | 2024-09-20 |
| How Does Medical Clown Intervention Affect the Length of Hospitalization in Children With Pneumonia Medical clown visits - Community-Acquired Pneumonia (CAP) | Not applicable | Completed | Carmel Medical Center | 51 | 2018-10-30 | 2024-12-27 |
| Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia ceftobiprole medocaril, IV standard-of-care cephalosporin - Community-acquired Pneumonia (CAP), Hospital-acquired Pneumonia (HAP) | Phase 3 | Completed | Basilea Pharmaceutica | 138 | 2017-11-27 | 2023-05-12 |
| Efficacy of High Doses Penicillin V Versus High Doses Amoxicillin in the Treatment of Non-severe Pneumonia. Penicillin V, Amoxicillin - Community-acquired Pneumonia (CAP) | Phase 3 | Terminated | Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | 43 | 2013-11-05 | 2017-07-05 |
| Evaluation of Effectiveness of the Treatment After Repeated Administration of Klacid®SR Tracheitis, Tracheobronchitis | Completed | Abbott | 3130 | 2010-02-01 | 2025-10-06 | |
| Safety and Efficacy Study of Oxazolidinone to Treat Pneumonia Radezolid - Community-Acquired Pneumonia (CAP) | Phase 2 | Completed | Melinta Therapeutics, Inc. | 158 | 2007-10-01 | 2016-05-12 |
| Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia IV azithromycin, ceftriaxone, oral azithromycin - Community-Acquired Pneumonia (CAP) | Phase 4 | Completed | Pfizer | 219 | 2001-01-01 | 2017-03-10 |
Community-Acquired Pneumonia (17) · Bronchitis (2) · Pneumonia (2) · Respiratory Tract Infections (2) · Angina Pectoris (1) · Asthma (1) · Bronchitis, Chronic (1) · Critical Illness (1) · Disease (1) · Emergencies (1) · Healthcare-Associated Pneumonia (1) · Influenza, Human (1) · Laryngitis (1) · Lymphopenia (1) · Nasopharyngitis (1)
Community-Acquired Infections (17) · Infections (17) · Respiratory Tract Diseases (17) · Pneumonia (15) · Respiratory Tract Infections (15) · Lung Diseases (7) · Pathological Conditions, Signs and Symptoms (6) · Pathologic Processes (5) · Disease Attributes (4) · Bronchial Diseases (3) · Lung Diseases, Obstructive (3) · Immune System Diseases (2) · Cardiovascular Diseases (1) · Chest Pain (1) · Chronic Disease (1)
Amoxicillin (1) · Azithromycin (1) · Ceftriaxone (1) · Levofloxacin (1) · Medicine, Chinese Traditional (1) · Penicillin V (1) · ceftobiprole (1) · ceftobiprole medocaril (1) · radezolid (1)
Pfizer (3) · Henan University of Traditional Chinese Medicine (2) · Abbott (1) · Basilea Pharmaceutica (1) · Carmel Medical Center (1) · Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina (1) · ImmunityBio, Inc. (1) · Jeffrey Pernica (1) · Marubeni Pharmaceuticals (Suzhou) Co., Ltd. (1) · Melinta Therapeutics, Inc. (1) · National Research Institute of Chinese Medicine, Ministry of Health and Welfare (1) · National Taiwan University Clinical Trial Center (1) · Shanghai Children's Medical Center (1) · University Hospital, Caen (1)
United States (4) · Canada (3) · China (3) · Spain (2) · Taiwan (2) · Bulgaria (1) · Czechia (1) · France (1) · Georgia (1) · Germany (1) · Greece (1) · Hungary (1) · Israel (1) · Romania (1) · Russia (1)
Adam Hloska, M.D. (1) · Haifeng Wang (1) · Jayson Garmizo (1) · Jiansheng Li, Doctor (1) · Marc Engelhardt, MD (1) · Yong Yin (1)